Abstract
Unrelated donor bone marrow transplants provide the alternative to allogeneic transplants for patients lacking an HLA-matched related family member donor. Because the donor and recipient have greater immunogenetic disparity than related donor transplants, these transplants are associated with a higher rate of immunologic complications. This disparity has also translated into a lower risk of relapse relative to sibling donor transplants, enabling this treatment to offer a cure to advanced-disease patients.
Original language | English (US) |
---|---|
Pages (from-to) | 84-88 |
Number of pages | 5 |
Journal | Current Opinion in Oncology |
Volume | 8 |
Issue number | 2 |
DOIs | |
State | Published - 1996 |
Externally published | Yes |
ASJC Scopus subject areas
- Oncology
- Cancer Research